JP7656339B2 - 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ - Google Patents

疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ Download PDF

Info

Publication number
JP7656339B2
JP7656339B2 JP2022501259A JP2022501259A JP7656339B2 JP 7656339 B2 JP7656339 B2 JP 7656339B2 JP 2022501259 A JP2022501259 A JP 2022501259A JP 2022501259 A JP2022501259 A JP 2022501259A JP 7656339 B2 JP7656339 B2 JP 7656339B2
Authority
JP
Japan
Prior art keywords
ibuprofen
tramadol
pain
pharma
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022501259A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021005129A5 (enExample
JP2022540854A (ja
Inventor
アントニオ、ポルトレス、ペレス
ルイス、ナルシソ、サンテ、セルナ
マリア、デル、ロサリオ、サラス、ブトロン
エミリオ、バルガス、カストリリョン
カルロス、カランドリア、ペレス
ラケル、オルカハダ、コルドバ
アンヘル、ホセ、ムニョス、ルイス
マルタ、ビカリオ、デ、ラ、トレ
ヌリア、サンス、メネデス
アントニア、ゴメス、カルボ
ホセ、アンヘル、サンチェス、ガルシア
エステル、ドゥアルト、ゴンザレス
フェルナンド、ガルシア、アロンソ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Publication of JP2022540854A publication Critical patent/JP2022540854A/ja
Publication of JPWO2021005129A5 publication Critical patent/JPWO2021005129A5/ja
Application granted granted Critical
Publication of JP7656339B2 publication Critical patent/JP7656339B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2022501259A 2019-07-09 2020-07-08 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ Active JP7656339B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09
EP19382583.3 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (3)

Publication Number Publication Date
JP2022540854A JP2022540854A (ja) 2022-09-20
JPWO2021005129A5 JPWO2021005129A5 (enExample) 2023-07-19
JP7656339B2 true JP7656339B2 (ja) 2025-04-03

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501259A Active JP7656339B2 (ja) 2019-07-09 2020-07-08 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ

Country Status (21)

Country Link
US (1) US20220249414A1 (enExample)
EP (1) EP3996699B1 (enExample)
JP (1) JP7656339B2 (enExample)
CN (1) CN114080221B (enExample)
AU (1) AU2020309160B2 (enExample)
BR (1) BR112022000242A2 (enExample)
CA (1) CA3145632C (enExample)
DK (1) DK3996699T3 (enExample)
ES (1) ES2952013T3 (enExample)
FI (1) FI3996699T3 (enExample)
HR (1) HRP20230677T1 (enExample)
HU (1) HUE062529T2 (enExample)
MA (1) MA56341B1 (enExample)
MD (1) MD3996699T2 (enExample)
MX (1) MX2022000373A (enExample)
MY (1) MY207573A (enExample)
PL (1) PL3996699T3 (enExample)
PT (1) PT3996699T (enExample)
RS (1) RS64500B1 (enExample)
SI (1) SI3996699T1 (enExample)
WO (1) WO2021005129A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013124498A1 (es) 2012-02-22 2013-08-29 Farmauder, S.A. Composición farmacéutica de ibuprofeno y tramadol para inyección

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
WO2015157738A1 (en) * 2014-04-10 2015-10-15 Charleston Laboratories, Inc. Pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013124498A1 (es) 2012-02-22 2013-08-29 Farmauder, S.A. Composición farmacéutica de ibuprofeno y tramadol para inyección

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ain-Shams J Anesthesiol，2013年，Vol.6，p.171-174

Also Published As

Publication number Publication date
EP3996699B1 (en) 2023-06-28
MY207573A (en) 2025-03-05
MX2022000373A (es) 2022-02-10
AU2020309160B2 (en) 2025-06-26
CA3145632A1 (en) 2021-01-14
DK3996699T3 (da) 2023-07-24
BR112022000242A2 (pt) 2022-05-31
AU2020309160A1 (en) 2022-02-17
WO2021005129A1 (en) 2021-01-14
ES2952013T3 (es) 2023-10-26
PT3996699T (pt) 2023-07-27
SI3996699T1 (sl) 2023-10-30
HUE062529T2 (hu) 2023-11-28
JP2022540854A (ja) 2022-09-20
RS64500B1 (sr) 2023-09-29
HRP20230677T1 (hr) 2023-10-13
PL3996699T3 (pl) 2023-10-30
US20220249414A1 (en) 2022-08-11
CN114080221B (zh) 2023-12-05
CA3145632C (en) 2024-03-12
MA56341B1 (fr) 2023-07-31
FI3996699T3 (fi) 2023-08-01
MD3996699T2 (ro) 2023-11-30
CN114080221A (zh) 2022-02-22
EP3996699A1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
KR102795284B1 (ko) 베타-히드록시부티레이트 및 부탄디올의 s-거울상이성질체 및 이의 사용 방법
RU2497512C2 (ru) Композиции на основе тапентадола для лечения боли
PT2701693T (pt) Tapentadol para prevenção e tratamento de depressão e ansiedade
US20110135723A1 (en) Pharmaceutical compositions containing pregabalin
US20080031950A1 (en) Novel anelgesic combination
CN1141937C (zh) 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物
JP5828609B2 (ja) 持続性解熱鎮痛消炎剤
ES2625142T5 (en) Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine
KR20170091775A (ko) 정맥 내 투여용 이부프로펜의 투여
JP2019507101A (ja) 含プレガバリン経口用徐放性三重錠剤
JP7656339B2 (ja) 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ
HK40067137A (en) Combination of ibuprofen and tramadol for relieving pain
HK40067137B (en) Combination of ibuprofen and tramadol for relieving pain
KR20150048890A (ko) 플루르비프로펜을 포함하는 약학적 조성물
WO2013115737A2 (en) New pharmaceutical compositions of flurbiprofen and glucosamin
US20060198886A1 (en) Medicament having coated methenamine combined with acidifier
TWI424850B (zh) 包含非類固醇類抗發炎藥物及秋水仙鹼甙(ｃｏｌｃｈｉｃｏｓｉｄｅ）衍生物之活性成分之新組合
JP2010174028A (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
JP4896647B2 (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
CN117750956A (zh) 用于治疗抑郁状态的方法
JP2013032408A (ja) 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
JP2013028647A (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
JP2010150284A (ja) 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240709

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241206

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250314

R150 Certificate of patent or registration of utility model

Ref document number: 7656339

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150